CD47 and Hodgkins lymphoma: Moreover, exploring the functional consequences of CD47 expression in HL, perhaps in the context of immune checkpoint inhibition or other immune-modulating therapies, may provide further insights into its role in the pathophysiology and treatment of this disease.